NASDAQ:STEX Biosig Technologies (STEX) Stock Price, News & Analysis $0.62 -0.02 (-2.94%) Closing price 09/18/2026 04:00 PM EasternExtended Trading$0.63 +0.01 (+1.44%) As of 09/18/2026 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsSEC Filings About Biosig Technologies Stock (NASDAQ:STEX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Biosig Technologies alerts:Sign Up Key Stats Today's Range$0.61▼$0.6650-Day Range$0.58▼$1.0452-Week Range$0.57▼$7.44Volume842,317 shsAverage Volume866,078 shsMarket Capitalization$71.98 millionP/E RatioN/ADividend YieldN/APrice Target$4.00Consensus RatingHold Company Overview BioSig Technologies, Inc. is a medical technology company focused on improving the diagnosis and treatment of cardiac arrhythmias. Its primary product is the PURE EP™ Platform, an electrophysiology system designed to acquire, process, and display intracardiac and surface cardiac signals during procedures. The PURE EP Platform is intended for use by electrophysiologists in hospitals and other clinical settings, where it can support the evaluation of abnormal heart rhythms and help guide catheter-based ablation procedures. The system is designed to provide high-fidelity signal visualization and noise reduction compared with conventional electrophysiology recording workflows. BioSig has historically focused its commercialization efforts on the United States and has worked with hospitals, physicians, and cardiac electrophysiology specialists. The company was previously publicly traded under the symbol BSGM. Information connecting BioSig Technologies with the symbol STEX, as provided, could not be independently verified.AI Generated. May Contain Errors. Read More Biosig Technologies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks43rd Percentile Overall ScoreSTEX MarketRank™: Biosig Technologies scored higher than 43% of companies evaluated by MarketBeat, and ranked 649th out of 846 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.4 / 5Analyst RatingHold Consensus RatingBiosig Technologies has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.Upside PotentialBiosig Technologies has a consensus price target of $4.00, representing about 547.1% upside from its current price of $0.62.Amount of Analyst CoverageBiosig Technologies has only been the subject of 2 research reports in the past 90 days.Read more about Biosig Technologies' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Biosig Technologies is -0.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Biosig Technologies is -0.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioBiosig Technologies has a P/B Ratio of 0.74. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted13.99% of the float of Biosig Technologies has been sold short.Short Interest Ratio / Days to CoverBiosig Technologies has a short interest ratio ("days to cover") of 7.83.Change versus previous monthShort interest in Biosig Technologies has recently increased by 4.19%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldBiosig Technologies does not currently pay a dividend.Dividend GrowthBiosig Technologies does not have a long track record of dividend growth. News and Social Media2.6 / 5News Sentiment0.11 News SentimentBiosig Technologies has a news sentiment score of 0.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.75 average news sentiment score of Finance companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Biosig Technologies this week, compared to 2 articles on an average week.Search InterestOnly 2 people have searched for STEX on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.MarketBeat Follows4 people have added Biosig Technologies to their MarketBeat watchlist in the last 30 days. Company Ownership1.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Biosig Technologies insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $52,336.00 in company stock.Percentage Held by Insiders52.73% of the stock of Biosig Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions7.16% of the stock of Biosig Technologies is held by institutions.Read more about Biosig Technologies' insider trading history. Receive STEX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Biosig Technologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. STEX Stock News HeadlinesStreamex Corp. Announces August 2026 Yield Dividend Distribution for GLDYSeptember 16 at 4:30 PM | globenewswire.comStreamex Corp. to Present at Sidoti’s Small-Cap Virtual Investor Conference September 23, 2026September 15, 2026 | markets.businessinsider.comThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free. | Reagan Gold Group (Ad)Streamex Corp. to Present at Sidoti's Small-Cap Virtual Investor Conference September 23, 2026September 15, 2026 | globenewswire.comBiosig Technologies (NASDAQ:STEX) Upgraded at Wall Street ZenSeptember 12, 2026 | americanbankingnews.comStreamex Corp. Appoints Laura Kiernan as Head of Investor RelationsSeptember 1, 2026 | globenewswire.comSiebert Partners with tZERO to Give Access to Digital Securities to Its CustomersAugust 20, 2026 | globenewswire.comStreamex to Participate as Innovator Partner at the Real-World Asset Summit in Brooklyn, New York; CEO Henry McPhie to Join Panel on Commodities Tokenization on September 2, 2026August 20, 2026 | globenewswire.comSee More Headlines STEX Stock Analysis - Frequently Asked Questions How have STEX shares performed this year? Biosig Technologies' stock was trading at $3.40 on January 26, 2026. Since then, STEX stock has decreased by 81.8% and is now trading at $0.6181. How were Biosig Technologies' earnings last quarter? Biosig Technologies, Inc. (NASDAQ:STEX) issued its quarterly earnings results on Friday, August, 14th. The company reported ($0.08) EPS for the quarter. The business had revenue of $0.15 million for the quarter. Read the conference call transcript. Is Biosig Technologies doing a stock buyback? Biosig Technologies' Board of Directors authorized a stock buyback plan on Tuesday, July 7th 2026, which permits the company to buy back 10,000,000,000,000 outstanding shares, according to EventVestor. This means that the company could reacquire up to 5.5% of its shares through open market purchases. Shares buyback plans are usually an indication that the company's board believes its stock is undervalued. How do I buy shares of Biosig Technologies? Shares of STEX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/14/2026Today9/19/2026Small-Cap Virtual Conference9/23/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (11m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 STEX's financial health is in the Yellow zone, according to TradeSmith. STEX has been in this zone for over 11 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorFinance Industry Capital Markets Sub-IndustryAsset Management & Custody Banks Current SymbolNASDAQ:STEX CIK1530766 Webwww.streamex.com Phone(203) 409-5444FaxN/AEmployees50Year Founded2009Price Target and Rating Average Price Target for Biosig Technologies$4.00 High Price Target$4.00 Low Price Target$4.00 Potential Upside/Downside+547.1%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)($9.05) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$462.77 million Net MarginsN/A Pretax Margin-344,630.84% Return on Equity-462.48% Return on Assets-307.38% Debt Debt-to-Equity RatioN/A Current Ratio20.20 Quick Ratio20.21 Sales & Book Value Annual Sales$40 thousand Price / Sales1,799.60 Cash FlowN/A Price / Cash FlowN/A Book Value$0.83 per share Price / Book0.74Miscellaneous Outstanding Shares116,460,000Free Float55,053,000Market Cap$71.98 million OptionableN/A Beta2.01 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NASDAQ:STEX) was last updated on 9/19/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biosig Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biosig Technologies With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.